Hoffmann-La Roche

SEP 9, 2026 · PHASE 1 TRIAL

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)

ClinicalTrials.gov

This is a Phase 1 clinical trial registry record with no results posted; it describes planned safety and tolerability assessment in a small early-stage cohort.

SEP 9, 2026 · PHASE 1 TRIAL

A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

ClinicalTrials.gov

This is a Phase 1 clinical trial registry record with no results posted; it describes a planned safety and drug-drug interaction study in a small healthy population.

SEP 9, 2026 · PHASE 3 TRIAL

A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer

ClinicalTrials.gov

This is a clinical trial registry record for an active Phase 3 study with no results posted; the record describes planned design and enrollment only.

SEP 8, 2026 · PHASE 3 TRIAL

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a clinical trial registry record describing a Phase 3 study that is currently recruiting with no results posted; it documents planned design and endpoints only.

SEP 4, 2026 · PHASE 2 TRIAL

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial currently recruiting; no results are posted in this registry record, making it an early-stage study with unknown efficacy and safety outcomes.

SEP 4, 2026 · PHASE 4 TRIAL

A Study to Investigate Mechanisms of Resistance to Breast Cancer Therapies

ClinicalTrials.gov

This is a recruiting Phase 4 mechanistic study with no results posted; it aims to characterize resistance mechanisms via tissue and blood biomarkers but has not yet generated outcome data.

AUG 17, 2026 · PHASE 3 TRIAL

A Study Evaluating the Efficacy and Safety of Giredestrant Combined With Palbociclib Compared With Letrozole Combined With Palbociclib in Participants With Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (persevERA Breast Cancer)

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is active but not recruiting, and primary outcome data are not yet available in this registry record.

AUG 14, 2026 · PHASE 3 TRIAL

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

ClinicalTrials.gov

This is an active Phase 3 registry record with no reported results; the study is still recruiting and outcome data are not yet available.